A global survey on changes in the supply, price and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic

Ali Farhoudian, Seyed Ramin Radfar, Hossein Mohaddes Ardabili, Parnian Rafei, Mohsen Ebrahimi, Arash Khojasteh Zonoozi, Cornelis A J De Jong, Mehrnoosh Vahidi, Masud Yunesian, Christos Kouimtsidis, Shalini Arunogiri, Helena Hansen, Kathleen T Brady, Marc N Potenza, ISAM-PPIG Global Survey Consortium, Alexander Mario Baldacchino, Hamed Ekhtiari
doi: https://doi.org/10.1101/2020.07.16.20155341

Article Information

doi 
https://doi.org/10.1101/2020.07.16.20155341
History 
  • July 24, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Ali Farhoudian1,2,
  2. Seyed Ramin Radfar3,
  3. Hossein Mohaddes Ardabili4,5,
  4. Parnian Rafei6,
  5. Mohsen Ebrahimi7,
  6. Arash Khojasteh Zonoozi5,
  7. Cornelis A J De Jong8,
  8. Mehrnoosh Vahidi2,
  9. Masud Yunesian9,
  10. Christos Kouimtsidis10,
  11. Shalini Arunogiri11,
  12. Helena Hansen12,
  13. Kathleen T Brady13,
  14. Marc N Potenza14,
  15. ISAM-PPIG Global Survey Consortium,
  16. Alexander Mario Baldacchino15 and
  17. Hamed Ekhtiari16,*
  1. 1Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  2. 2Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran
  3. 3University of California, Los Angeles, Integrated Substance Abuse Programs Department, USA
  4. 4Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6Department of Psychology, Faculty of Psychology and Education, University of Tehran, Iran
  7. 7Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Iran
  8. 8Radboud University, Netherlands
  9. 9School of Public Health, Tehran University of Medical Sciences, Iran
  10. 10Surrey and Borders Partnership NHS Foundation Trust, UK
  11. 11Turning Point, Eastern Health, Box Hill, Australia
  12. 12Departments of Anthropology and Psychiatry, New York University, USA
  13. 13Medical University of South Carolina, USA
  14. 14Yale School of Medicine, Connecticut Council on Problem Gambling and Connecticut Mental Health Center, USA
  15. 15Division of Population and Behaviour Sciences, Medical School, University of St Andrews, St Andrews, Fife, Scotland, United Kingdom
  16. 16Laureate Institute for Brain Research, Tulsa, OK, USA
  17. 1National Institute for Infectious Diseases, Prof. Dr. Matei Bals- Arena OMT Department, Romania
  18. 2Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Cameroon
  19. 3Alamal psychiatric hospital, Dubai, United Arab Emirates
  20. 4Sydney Medical School, University of Sydney, NSW, Australia
  21. 5Al Ahliyya Amman University, Amman, Jordan
  22. 6Ministry of Health, Muscat, Oman
  23. 7Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India
  24. 8State Drug Dependence Treatment Centre, Institute of Mental Health, Pt BDS University of Health Sciences, India
  25. 9Department of Psychiatry, College of Medicine, University of Ibadan, Nigeria
  26. 10Addiction medicine clinic, Jordan
  27. 11Drug De-addiction & Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India
  28. 12Addiction medicine clinic, Mila, Algeria
  29. 13Centre medical Marmottan, France
  30. 14Réseau de Prévention des Addictions (RESPADD), France
  31. 15Department of Psychiatry and Behavioural Neurosciences, Michael DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
  32. 16Geneva University Hospitals, Switzerland
  1. ↵*Corresponding Author:
    Hamed Ekhtiari, MD, PhD, Associate Investigator, Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136-3326, Phone: (+1-918) 502 5120; email: hekhtiari{at}laureateinstitute.org
    1. 17United Nations Office on Drugs and Crime (UNODC), Vienna, Austria
    2. 18CUNY School of Medicine, New York, USA
    3. 19Aġenzija Sedqa, Malta
    4. 20Department of Medicine and Surgery, University Milan-Bicocca, Italy
    5. 21University Psychiatric Hospital Vrapce - Zagreb, Croatia
    6. 22Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway
    7. 23Department of Biochemistry, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India
    8. 24Addiction medicine clinic, Mexico
    9. 25Addiction Crisis Solutions, USA
    10. 26Department of Psychology, Indiana University Purdue University - Indianapolis, USA
    11. 27SerT Lentini, ASP Siracusa, Italy
    12. 28Rebirth Charity Society NGO, Tehran, Iran
    13. 29Serenity Vista Addiction Treatment Center, Panama
    14. 30Department of Psychiatry, ESIC Medical College, Hyderabad, Telangana, India
    15. 31National Institute of Mental Health, Czech Republic
    16. 32Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Belgium
    17. 33Drug & Alcohol Clinical Services, Hunter New England Local Health District, Australia
    18. 34Ain Shams University, Cairo, Egypt
    19. 35Department of Neurology and Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    20. 36Centre for Research and Information on Substance Abuse, Nigeria
    21. 37Addiction medicine clinic, Syria
    22. 38European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Italy
    23. 39Department of Psychiatry, Aristotle University of Thessaloniki, Greece
    24. 40Brown University and Lifespan Health System, Providence, Rhode Island, USA
    25. 41Fuderanan Mental Health Clinic, Philippines
    26. 43Georgian Harm Reduction Network, Georgia
    27. 44Organization Against Drugs, Primary Care Health Center, Veria, Greece
    28. 45Addictions Services (Ser.D.), Department of Territorial Services, ASL Teramo, Italy
    29. 46Swansea University Medical School, Institute of Life Sciences 2, Singleton Campus, SA2 8PP, Wales, UK
    30. 47Universidad de Buenos Aires, Argentina
    31. 48University of Sydney, Australia
    32. 49Institutes for Cognitive Science Studies (IRICSS), Brain and Cognition Clinic, Tehran, Iran
    33. 50Tehran University of Medical Sciences, Tehran, Iran
    34. 51Department of Anesthesiology, Yale University, USA
    35. 52Drugs Rehabilitation Center, National Narcotics Board of Indonesia, Indonesia
    36. 53Department of Psychiatry, Universitas Padjadjaran, Bandung, West Java, Indonesia
    37. 54National Institute of Education, Sri Lanka
    38. 55Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India
    39. 56Univeristi Malaysia Sabah, Malaysia
    40. 57Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran
    41. 58National Center for Mental Health of Korea, South Korea
    42. 59Republican Center for Addictive Disorders, Lithuania
    43. 60Addiction medicine clinic, North Macedonia
    44. 61Naufar Institute, Doha, Qatar
    45. 62The Kantchelov Clinic, Sofia, Bulgaria
    46. 63Mount Sinai Medical Center, New York, USA
    47. 64African Institute for Development Policy, Malawi
    48. 65Sobriety Centers of New Hampshire, USA
    49. 66Federal University of Rio Grande do Sul, Brazil
    50. 67Pusan National University Yangsan Hospital, Department of Neuropsychiatry, Yangsan South Korea
    51. 68Chatham House, USA
    52. 69Institute for Public Health of Split-Dalmatia County, Croatia
    53. 70Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Indonesia
    54. 71Scripps Mercy Hospital, San Diego, United States (USA)
    55. 72Department of Psychiatry, The Catholic University of Korea, Seoul, Korea
    56. 73Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania
    57. 74Israel Center on Addiction, Netanya, Israel
    58. 75Community Health Work, Tanzania
    59. 76Hayat Center for Treatment and Psycho-social Rehabilitation, Khartoum, Sudan
    60. 77University of Botswana, Botswana
    61. 78V.P. Dole, Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, Italy
    62. 79CAS Girona, Department of Psychology, University of Girona, Spain
    63. 81Community addiction team, Southern Health and Social Care Trust, Northern Ireland, UK
    64. 82Priority Medical Clinic, Dublin, Ireland
    65. 83Save the Children International Organization, Burma
    66. 84Dirección de Investigaciones Epidemiológicas y Sociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, México
    67. 85Department of Psychiatry, Faculty of Medicine, Sir John Kotelawala Defence University, Sri Lanka
    68. 86Centre for Addiction Medicine, NIMHANS, Bangalore, India
    69. 87Kleopatra Kodric, Irena Nisic, Slovenia
    70. 88Alcohol Tobacco and Other Drug Research Unit, South African Medical Research Council, South Africa
    71. 89NIMHANS, Bangalore, India
    72. 90Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India
    73. 91Federal Neuropsychiatric Hospital, Calabar, Nigeria
    74. 92Department of Psychiatry, Psychosomatic Research Center, Tehran University of Medical Sciences, Tehran, Iran
    75. 93Institute of Psychiatry, WHO Collaborating Center for Mental Health, Pakistan
    76. 94Brijder Addiction Care, Zaandam, the Netherlands
    77. 95Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy
    78. 96Koh Kong Provincial Hospital, Cambodia
    79. 97Kaiser Permanente, USA
    80. 98Psychiatric hospital Sveti Ivan, Zagreb, Croatia
    81. 99Department of Psychiatry and mental health, Institute of Medicine, Tribhuvan University, Nepal
    82. 100Universidad de El Salvador, El Salvador
    83. 101AddiPsy, Lyon, France
    84. 102Addiction medicine clinic, Costa Rica
    85. 103Novadic-Kentron Addiction Care Network, Vught, The Netherlands
    86. 104Phoenix Foundation for Research and Development, Pakistan
    87. 105Barwon Health, Geelong, Australia
    88. 106Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
    89. 107University of the Sunshine Coast (USC), Queensland, Australia
    90. 108Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    91. 109Drugs Rehabilitation Center, National Narcotics Board of Indonesia
    92. 110Department of Cognitive Psychology, Institute for Cognitive Science Studies, Tehran, Iran
    93. 111Usher Institute, University of Edinburgh, EH8 9AG United Kingdom
    94. 112Psychiatry Service, University of Salamanca Health Care Complex, Salamanca (Spain)
    95. 113PGIMER, Chandigarh, India
    96. 114Street Health Centre, Canada
    97. 115Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck Austria
    98. 116Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
    99. 117Medical School, University of Cyprus, Cyprus
    100. 118Clínica Psiquiátrica de la Facultad de Medicina, Uruguay
    101. 119Center for Treatment od Drug addiction, University Psychiatric Clinic, Ljubljana, Slovenia
    102. 120Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Lagankhel, Nepal
    103. 121Department of Psychiatry, Second Xiangya Hospital, Central South University, China
    104. 122Department of Psychiatry, Teine Keijinkai Medical Center, Japan
    105. 123David Geffen School of Medicine at UCLA, Department of Family Medicine, USA
    106. 124Health Professions Councils of Namibia, Namibia
    107. 125Addiction medicine clinic, Uruguay
    108. 127Asociasion Programa Andres Argentina, Argentina
    109. 128Mazandaran University of Medical Sciences, Mazandaran, Iran
    110. 129MRC/CSO SPHSU, University of Glasgow, United Kingdom
    111. 130Gladsaxe Substance Use Disorder Treatment Centre, Denmark
    112. 131Institut de Neuropsiquiatria i Addiccions, IMIM-Hospital del Mar, Medical Research Barcelona, Spain
    113. 132NACADA, Kenya
    114. 133Waikato District Health Board (WDHB) Hamilton, New Zealand
    115. 134Institute of Addiction Medicine, USA
    116. 135Jellinek, Amsterdam, Netherlands
    117. 136Addictions Foundation of Manitoba, Canada
    118. 137Thanyarak Chiangmai hospital, Thailand
    119. 138Medical University of Warsaw, Warsaw, Poland
    120. 139Jimma University, Ethiopia
    121. 140Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, China
    Back to top
    Posted July 24, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email
    A global survey on changes in the supply, price and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic
    Ali Farhoudian, Seyed Ramin Radfar, Hossein Mohaddes Ardabili, Parnian Rafei, Mohsen Ebrahimi, Arash Khojasteh Zonoozi, Cornelis A J De Jong, Mehrnoosh Vahidi, Masud Yunesian, Christos Kouimtsidis, Shalini Arunogiri, Helena Hansen, Kathleen T Brady, Marc N Potenza, ISAM-PPIG Global Survey Consortium, Alexander Mario Baldacchino, Hamed Ekhtiari
    medRxiv 2020.07.16.20155341; doi: https://doi.org/10.1101/2020.07.16.20155341
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools

    Subject Area